Company
Hawkhill Therapeutics
Claim, correct or request removal
Record updated 28 September 2026
About
Hawkhill is developing a first-in-class oral small-molecule therapy for obesity designed to deliver meaningful fat loss while preserving muscle mass, addressing an increasingly recognised limitation of current weight-loss treatments.
Loading relationship preview